Cyclosporine induces progressive attenuation of baroreceptor heart rate response and cumulative pressor response in conscious unrestrained rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 305, Issue 3, 2003, Pages 966-973

  Shaltout, Hossam A ^a   Abdel Rahman, Abdel A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HEART RATE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRESSORECEPTOR; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; SHORT COURSE THERAPY; SINGLE DRUG DOSE; TESTOSTERONE BLOOD LEVEL;

ANIMALS; BAROREFLEX; BLOOD PRESSURE; CYCLOSPORINE; HEART RATE; IMMUNOSUPPRESSIVE AGENTS; MALE; PRESSORECEPTORS; RATS; RATS, SPRAGUE-DAWLEY; TESTOSTERONE;

EID: 0038137548     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.048447     Document Type: Article

References (36)

1. Abdel-Rahman AA (1994) Differential effects of ethanol on baroreceptor heart rate responses of conscious spontaneously hypertensive and normotensive rats. Alcohol Clin Exp Res 18:1515-1522.
2. Abdel-Rahman AR, Merrill RH, and Wooles WR (1994) Gender-related differences in the baroreceptor reflex control of heart rate in normotensive humans. J Appl Physiol 77:606-613.
3. Abdel-Rahman AA and Wooles WR (1987) Ethanol-induced hypertension involves impairment of baroreceptors. Hypertension 10:67-73.
4. Cartier R, Dagenais F, Hollmann C, Cambron H, and Buluran J (1994) Chronic exposure to cyclosporine affects endothelial and smooth muscle reactivity in the rat aorta. Ann Thorac Surg 58:789-794.
5. Cohen DJ, Loertscher R, Rubin MF, Tilney NL, Carpenter CB, and Strom TB (1984) Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med 101:667-682.
6. El-Mas MM, Afify EA, Mohy El-Din MM, Omar AG, and Sharabi FM (2001) Testosterone facilitates the baroreceptor control of reflex bradycardia: role of cardiac sympathetic and parasympathetic components. J Cardiovasc Pharmacol 38:754-763.
7. El-Mas MM, Afify EA, Omar AG, and Sharabi FM (2002) Cyclosporine adversely affects baroreflexes via inhibition of testosterone modulation of cardiac vagal control. J Pharmacol Exp Ther 301:346-354.
8. Farthing MJ and Clark ML (1981) Nature of the toxicity of cyclosporin A in the rat. Biochem Pharmacol 30:3311-3316.
9. Fernandez-Miranda C, Sanz M, De La Calle A, Loinaz C, Gomez R, Jimenez C, Garcia I, Gomez De La Camara A, and Moreno E (2002) Cardiovascular risk factors in 116 patients 5 years or more after liver transplantation. Transpl Int 15:556-562.
10. Gerhardt U, Riedasch M, and Hohage H (1999) Cyclosporine A modulates baroreceptor function in kidney transplant recipients. Int J Cardiol 68:203-208.
11. Goldstein DS (1983) Arterial baroreflex sensitivity, plasma catecholamines and pressor responsiveness in essential hypertension. Circulation 68:234-240.
12. Gordon FJ and Mark AL (1983) Impaired baroreflex control of vascular resistance in prehypertensive Dahl S rats. Am J Physiol 245:H210-H217.
13. Grieff M, Loertscher R, Shohaib SA, and Stewart DJ (1993) Cyclosporine-induced elevation in circulating endothelin-1 in patients with solid-organ transplants. Transplantation 56:880-884.
14. Janas J, Sitkiewicz D, Warnawin K, and Janas RM (1994) Characterization of a novel, high-molecular weight, acidic, endothelin-1 inactivating metalloendopeptidase from the rat kidney. J Hypertens 12:1155-1162.
15. Jaramillo-Juarez F, Rodriguez-Vazquez ML, Namorado MC, Martin D, and Reyes JL (2000) Acidosis and weight loss are induced by cyclosporin A in uninephrectomized rats. Pediatr Nephrol 14:122-127.
16. Kaye D, Thompson J, Jennings G, and Esler M (1993) Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation. Circulation 88:1101-1109.
17. Krueger BA, Trakshel GM, Sluss PM, and Maines MD (1991) Cyclosporin-mediated depression of luteinizing hormone receptors and heme biosynthesis in rat testes: a possible mechanism for decrease in serum testosterone. Endocrinology 129:2647-2654.
18. Leal AM and Moreira AC (1997) Daily variation of plasma testosterone, androstenedione and corticosterone in rats under food restriction. Horm Behav 31:97-100.
19. Lo Russo A, Passaquin AC, and Ruegg UT (1997) Mechanism of enhanced vasoconstrictor hormone action in vascular smooth muscle cells by cyclosporin A. Br J Pharmacol 121:248-252.
20. Lucini D, Milani RV, Ventura HO, Mehra MR, Messerli F, and Pagani M (2000) Study of arterial and autonomic effects of cyclosporine in humans. Hypertension 35:1258-1263.
21. Lyson T, McMullan DM, Ermel LD, Morgan BJ, and Victor RG (1994) Mechanism of cyclosporine-induced sympathetic activation and acute hypertension in rats. Hypertension 23:667-675.
22. Moeller H, Goecke B, and Herter F (1988) Seasonal and diurnal changes of prostatic androgen receptor and circulating testosterone in young mature rats. Res Exp Med 188:451-462.
23. Morgan BJ, Lyson T, Scherrer U, and Victor RG (1991) Cyclosporine causes sympathetically mediated elevations in arterial pressure in rats. Hypertension 18:458-466.
24. Moss NG, Powell SL, and Falk RJ (1985) Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci USA 82:8222-8226.
25. Olivari MT, Antolick A, and Ring WS (1989) Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy. J Heart Transplant 8:34-39.
26. Oriji GK and Keiser HR (1999) Nitric oxide in cyclosporine A-induced hypertension: role of protein kinase C. Am J Hypertens 12:1091-1097.
27. Rajfer J, Sikka SC, Lemmi C, and Koyle MA (1987) Cyclosporine inhibits testosterone biosynthesis in the rat testis. Endocrinology 121:586-589.
28. Ryuzaki M, Stahl LK, Lyson T, Victor RG, and Bishop VS (1997) Sympathoexcitatory response to cyclosporin A and baroreflex resetting. Hypertension 29:576-582.
29. Sander M, Lyson T, Thomas GD, and Victor RG (1996) Sympathetic neural mechanisms of cyclosporine-induced hypertension. Am J Hypertens 9 121S-138S.
30. Schachter M (1988) Cyclosporine A and hypertension. J Hypertens 6:511-516.
31. Stein CM, He H, Pincus T, and Wood AJ (1995) Cyclosporine impairs vasodilation without increased sympathetic activity in humans. Hypertension 26:705-710.
32. Sturrock ND, Lang CC, and Struthers AD (1993) Cyclosporin-induced hypertension precedes renal dysfunction and sodium retention in man. J Hypertens 11:1209-1216.
33. Xue H, Bukoski RD, McCarron DA, and Bennett WM (1987) Induction of contraction in isolated rat aorta by cyclosporine. Transplantation 43:715-718.
34. Zhang W, Li J-L, Hosaka M, Janz R, Shelton JM, Albright GM, Richardson JA, Sudhof TC, and Victor RG (2000) Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings. Proc Natl Acad Sci USA 97:9765-9770.
35. Zhang W and Victor RG (2000) Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension. Am J Hypertens 13:999-1004.
36. Zhao FK, Chuang LF, Israel M, and Chuang RY (1989) Cremophor EL, a widely used parenteral vehicle, is a potent inhibitor of protein kinase C. Biochem Biophys Res Commun 159:1359-1367.